Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash Flows From Operating Activities
Net income	$ 17,892	$ 32,452
Adjustments to reconcile net income to net cash provided by (used in) operating activities
Net accretion of bond premium	5,101	7,203
Depreciation and amortization	3,411	3,175
Stock-based compensation expense	1,762	2,115
Net investment (gains) losses	21,397	(30,512)
Net cash flows from equity and trading investments	29,161	40,983
Deferred income tax expense (benefit)	(6,602)	2,582
Changes in:
Accrued investment income	(683)	789
Premiums receivable	(56,235)	(16,975)
Deferred policy acquisition costs	(12,644)	(9,192)
Reinsurance receivables	(7,712)	35,755
Prepaid reinsurance premiums	(1,295)	614
Income taxes receivable	(1,270)	3,926
Other assets	(2,444)	(10,372)
Losses and loss settlement expenses	(54,437)	(9,678)
Unearned premiums	37,880	9,326
Accrued expenses and other liabilities	6,808	(19,077)
Other, net	4,036	(8,284)
Cash from operating activities	(33,766)	2,378
Net cash provided by (used in) operating activities	(15,874)	34,830
Cash Flows From Investing Activities
Proceeds from sale of available-for-sale investments	65,010	116,664
Proceeds from call and maturity of available-for-sale investments	104,349	153,567
Proceeds from sale of other investments	2,382	2,214
Purchase of investments in mortgage loans	(103)	0
Purchase of investments available-for-sale	(186,520)	(255,489)
Purchase of other investments	(3,344)	(4,663)
Net purchases and sales of property and equipment	697	(7,594)
Net cash provided by (used in) investing activities	(17,529)	4,699
Cash Flows From Financing Activities
Issuance of common stock	1,028	(412)
Repurchase of common stock	0	(1,007)
Payment of cash dividends	(7,795)	(7,539)
Net cash used in financing activities	(6,767)	(8,958)
Net Change in Cash and Cash Equivalents	(40,170)	30,571
Cash and Cash Equivalents at Beginning of Period	132,104	87,948
Cash and Cash Equivalents at End of Period	$ 91,934	$ 118,519